Transaction · 0001214659-26-010645

Finn Patrick John

Finn Patrick John, PRES, reported a transaction classified as exercise at Twist Bioscience Corp involving 23355.000000 shares for an estimated $0.00. Reported holdings after the transaction were 0.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MPRES
TWSTTwist Bioscience Corp
Estimated value$0Shares × reported price
Shares traded23.3k$0.00 per share
Holdings after0Direct
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

TWST price since this filing

Daily closing prices, with the filing date and available return windows
TWST · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -31.1%1w ago -9.6%1d ago -8.7%
Returns since7d +12.4%30d +22.6%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001214659-26-010645
Stock Option (right to buy)
Transaction date
Aug 18, 2026
Filed Aug 20, 2026, 08:05 PM · 2d delay
Shares
23,355 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
0 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership 10b5-1 Detected
Filing-only score

-16 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President and COO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The transactions reported on this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 18, 2026.

  2. F2

    Represents the weighted average sales price per share. The shares sold at prices ranging from $115.35 to $116.33 per share. Full information regarding the number of shares sold at each price shall be…

  3. F3

    Represents the weighted average sales price per share. The shares sold at prices ranging from $116.37 to $117.36 per share. Full information regarding the number of shares sold at each price shall be…

  4. F4

    Represents the weighted average sales price per share. The shares sold at prices ranging from $117.37to $118.19 per share. Full information regarding the number of shares sold at each price shall be p…

  5. F5

    Represents the weighted average sales price per share. The shares sold at prices ranging from $118.505 to $119.45 per share. Full information regarding the number of shares sold at each price shall be…

  6. F6

    Represents the weighted average sales price per share. The shares sold at prices ranging from $119.515 to $120.2 per share. Full information regarding the number of shares sold at each price shall be…

  7. F7

    Represents the weighted average sales price per share. The shares sold at prices ranging from $120.585 to $121.53 per share. Full information regarding the number of shares sold at each price shall be…

  8. F8

    Represents the weighted average sales price per share. The shares sold at prices ranging from $122.00 to $122.815 per share. Full information regarding the number of shares sold at each price shall be…

  9. F9

    The option was 100% exercisable on December 19, 2022.

Original filing · 0001214659-26-010645
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TWST